Friday 6 November 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024.

Revenue: +6.83%
EPS: −20.5%
Free cash flow: +21.1%
Total debt: +5.17%

Quarter to September 2026, against a year earlier

166.96 0.61 −0.36%

Follow GILD

Alert me

Market cap: $207.8B
P/E: 0.0×
Fwd P/E: −41.3×
Dividend yield: 1.95%
F-score: 8/9
Altman Z: 4.03
Beneish M: −2.45
Dividend safety: 77/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	8	9	5	5
ROE Full definition →		40.66%	43.36%	(20.68%)	(22.45%)
ROA Full definition →		14.42%	16.35%	(6.17%)	(7.03%)
ROIC Full definition →		15.69%	17.07%	(4.48%)	(4.51%)
Return on Tangible Assets Full definition →		70.13%	62.26%	(36.99%)	(39.37%)
Average Days of Receivables Full definition →		60.91	58.19	60.58	58.98
Free Cash Flow per Share Full definition →		7.60	8.24	10.41	11.10
Free Cash Flow Full definition →		9,456.00	10,230.00	12,943.00	13,780.00
Capital Expenditures Full definition →		(563.00)	(576.00)	(609.00)	(699.00)
Other line items
Cash ROIC Full definition →		17.13%	19.21%	31.44%	30.20%
Accounts Receivable Turnover Full definition →		6.31	6.51	6.19	6.14
Accounts Payable Turnover Full definition →		8.05	8.88	9.90	7.14
Inventory Turnover Full definition →		3.58	3.34	3.29	2.00
Average Days of Payables Full definition →		41.86	38.35	39.57	54.82
Days of Inventory on Hand Full definition →		103.87	113.80	114.66	259.65
Tax Rate Full definition →		(0.13)	(0.14)	0.66	0.52
Research and Development Expense of Revenue Full definition →		19.70%	19.48%	19.91%	20.42%
Selling, General and Administrative Expense of Revenue Full definition →		19.61%	20.07%	21.42%	21.97%
Share Based Compensation of Revenue Full definition →		3.04%	3.04%	2.98%	2.95%
Interest Coverage Full definition →		9.79	10.33	(2.51)	(2.34)
Operating CF/Net income Full definition →		1.18	1.17	(4.18)	(3.75)
Depreciation/Fixed assets Full definition →		0.49	0.49	0.47	0.47
Capex/Depreciation Full definition →		(0.20)	(0.21)	(0.22)	(0.25)
Revenue per Share Full definition →		23.67	23.94	24.50	24.95
Operating CF per Share Full definition →		8.05	8.70	10.90	11.66
Capex per Share Full definition →		(0.45)	(0.46)	(0.49)	(0.56)
Capex to Sales Full definition →		0.02	0.02	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly